Wundrsight

Wundrsight

Private
BangaloreHealthcare & Life Scienceshttp://www.wundrsight.com

Last Round

Seed

Sep 12, 2024

Total Funding Raised

$400,000

Company Overview

Wundrsight is a digital therapeutics company that provides a VR-powered digital therapeutics (DTx) platform for mental health.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, AR/VR Experiences, Medical AI, Telemedicine

Business Model

B2B

Customer Profile

Subscription SaaS, Hardware + Subscription, Government Contracts

AI Layer

Application

Keywords

digital therapeuticsVR therapyDTxmental healthcare platformdigital mental healthVR exposure therapyclinician-led therapybehavioral health platformsubstance use disorder treatmentanxiety and phobia treatmentOCD treatmentimmersive therapiesADHD and autism therapyAI-powered mental healthmedication-free therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Wundrsight Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Wundrsight Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedSep 12, 2024

Key People

Founding team and executive leadership

Nishtha Budhiraja ️‍

Chief Medical Officer, Principal Psychologist And Co-Founder At Wundrsight Health, Chief People Officer

Founding Team

Raunak Swarnkar

Co-Founder & CEO

Founding Team

Wundrsight Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 22, 2026

    Monthly visitors grew 413% MoM, from 99 to 508.

  • May 5, 2025

    Grew 23% QoQ, from 13 to 16 employees.

Wundrsight Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Wundrsight Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Wundrsight's valuation, stock price, and market status.

Firmographic Details

HeadquartersBangalore
Employee Range13
Year Founded2022
Last FundingSep 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.